{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:54:00Z","timestamp":1782316440122,"version":"3.54.5"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Acid-suppressive medications, including proton pump inhibitors (PPIs) and H2 receptor antagonists (H2RAs), are commonly used during pregnancy; however, concerns have emerged about their potential impact on gut and immune development in children.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the association between prenatal exposure to acid-suppressive medications and the risk of inflammatory bowel disease (IBD), including Crohn disease (CD) and ulcerative colitis (UC).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This nationwide cohort study assessed mother-child pairs from the National Health Insurance Service of South Korea identified between January 1, 2009, and December 31, 2017, with follow-up through December 31, 2023. Offspring exposed to acid-suppressive medications were matched 1:3 to those who were unexposed.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Prenatal exposure to 1 or more prescriptions for PPIs or H2RAs.<\/jats:p>\n <\/jats:sec>\n \n Main outcomes and Measures<\/jats:title>\n Incident risk of IBD, UC, and CD in children. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) with corresponding 95% CIs. Subgroup analysis was conducted by medication type, timing of exposure, prescription count, maternal gastrointestinal history, and sibling comparisons (to control for shared familial factors).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n After 1:3 PS matching, 1\u202f837\u202f916 mother\u2013child pairs were included (mean [SD] maternal age, 32.1 [4.7] years; 913\u202f260 [49.7%] female infants). Prenatal exposure to acid-suppressive medications was associated with an elevated risk of IBD (HR, 1.08; 95% CI, 1.01 to 1.15), with a significant association observed for CD (1.10; 95% CI, 1.02 to 1.19) but not for UC (1.04; 95% CI, 0.93 to 1.17). There was no evidence of difference in absolute risk differences (RD) for IBD (RD, 0.41 per 1000 children; 95% CI, \u22120.97 to 1.79), CD (RD, 0.51; 95% CI, \u22120.98 to 2.00), and UC (RD, 0.21; 95% CI, \u22121.56 to 1.97). In sibling comparison analyses, no significant associations were observed for IBD (HR, 1.06; 95% CI, 0.88-1.27), CD (1.03; 95% CI, 0.84-1.27), or UC (1.10; 95% CI, 0.78-1.55).<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, offspring exposed to acid-suppressive medications during pregnancy with sibling analyses showed no clear association with adverse outcomes. These findings suggest that in clinical settings, the minimal potential risk to the offspring should be carefully balanced against the therapeutic need for acid-suppressive treatment during pregnancy, supporting use when clinically indicated.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.20030","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:32:46Z","timestamp":1782315166000},"page":"e2620030","source":"Crossref","is-referenced-by-count":0,"title":["Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children"],"prefix":"10.1001","volume":"9","author":[{"given":"Jiyeon","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyu","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjee","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesu","family":"Jo","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Regulatory Science, Kyung Hee University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Regulatory Science, Kyung Hee University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeona","family":"Jo","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Precision Medicine, Kyung Hee University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohyun","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooji","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Woo","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerin","family":"Hwang","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea"},{"name":"Department of Electronics and Information Convergence Engineering, Kyung Hee University, Yongin, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea"},{"name":"Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea"},{"name":"Department of Electronics and Information Convergence Engineering, Kyung Hee University, Yongin, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"10S","key":"zoi260557r1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14309\/ajg.0000000000001958","article-title":"Heartburn, nausea, and vomiting during pregnancy.","volume":"117","author":"Dunbar","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"22","key":"zoi260557r2","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects.","volume":"363","author":"Pasternak","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260557r3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamapediatrics.2022.5193","article-title":"Prenatal and infant exposure to acid-suppressive medications and risk of allergic diseases in children.","volume":"177","author":"Noh","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi260557r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50366","article-title":"Association between proton pump inhibitor use during early pregnancy and risk of congenital malformations.","volume":"6","author":"Choi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi260557r5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents.","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi260557r6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/01.MIB.0000442921.77945.09","article-title":"Phenotype and disease course of early-onset pediatric inflammatory bowel disease.","volume":"20","author":"Aloi","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"zoi260557r7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S2352-4642(17)30017-2","article-title":"Early-onset paediatric inflammatory bowel disease.","volume":"1","author":"Ashton","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"zoi260557r8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/gutjnl-2012-303954","article-title":"Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.","volume":"62","author":"Knights","year":"2013","journal-title":"Gut"},{"issue":"5","key":"zoi260557r9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ibd.21805","article-title":"Cesarean section and offspring\u2019s risk of inflammatory bowel disease: a national cohort study.","volume":"18","author":"Bager","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"zoi260557r10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"zoi260557r11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/gutjnl-2022-327845","article-title":"Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study.","volume":"72","author":"Faye","year":"2023","journal-title":"Gut"},{"issue":"4","key":"zoi260557r12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/19490976.2017.1284732","article-title":"The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.","volume":"8","author":"Imhann","year":"2017","journal-title":"Gut Microbes"},{"issue":"5","key":"zoi260557r13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome.","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"issue":"5","key":"zoi260557r14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","article-title":"Background and data configuration process of a nationwide population-based study using the korean national health insurance system.","volume":"38","author":"Song","year":"2014","journal-title":"Diabetes Metab J"},{"key":"zoi260557r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116117","article-title":"Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: a nationwide birth cohort study in South Korea.","volume":"340","author":"Oh","year":"2024","journal-title":"Psychiatry Res"},{"key":"zoi260557r16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076885","article-title":"Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population based cohort study.","volume":"385","author":"Choi","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"zoi260557r17","doi-asserted-by":"publisher","DOI":"10.1111\/pai.14114","article-title":"Prenatal and postnatal exposure to antibiotics and risk of food allergy in the offspring: a nationwide birth cohort study in South Korea.","volume":"35","author":"Oh","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"issue":"10","key":"zoi260557r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"7","key":"zoi260557r19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.2025.23956","article-title":"Prenatal exposure to acid-suppressive medications and risk of neuropsychiatric disorders in children.","volume":"335","author":"Hong","year":"2026","journal-title":"JAMA"},{"issue":"12","key":"zoi260557r20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-331904","article-title":"Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study.","volume":"73","author":"An","year":"2024","journal-title":"Gut"},{"issue":"1","key":"zoi260557r21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: what is it and how does it work?","volume":"20","author":"Azur","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"key":"zoi260557r22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077664","article-title":"Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea.","volume":"385","author":"Kang","year":"2024","journal-title":"BMJ"},{"issue":"7","key":"zoi260557r23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1001\/jama.2025.22234","article-title":"Sibling comparisons to account for confounding in observational studies.","volume":"335","author":"Ahlqvist","year":"2026","journal-title":"JAMA"},{"issue":"8","key":"zoi260557r24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.28850","article-title":"Traumatic brain injury and risk of malignant brain tumors in civilian populations.","volume":"8","author":"Marini","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"12","key":"zoi260557r25","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1001\/jamaoncol.2017.2797","article-title":"Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio.","volume":"3","author":"Pak","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi260557r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.55430","article-title":"Sex differences in long COVID.","volume":"8","author":"Shah","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi260557r27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","article-title":"Recommendations for presenting analyses of effect modification and interaction.","volume":"41","author":"Knol","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi260557r28","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1053\/j.gastro.2021.08.005","article-title":"Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of 3 prospective cohorts.","volume":"161","author":"Xia","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"zoi260557r29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5863\/1551-6776-24.6.489","article-title":"Proton pump inhibitors, H2 blocker use, and risk of inflammatory bowel disease in children.","volume":"24","author":"Schwartz","year":"2019","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850680\/oh_2026_oi_260557_1781620485.31244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:32:47Z","timestamp":1782315167000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.20030","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}